Quick View

A A

Jan 24 2013, 01:09 IST

2012 rose to R9.61 Cr from R 7.30 crore a year earlier.

Transgene inks pact with Portugal’s Atral Cipan

Biotechnology firm Transgene Biotek has entered into a licencing pact with Portugal-based Atral Cipan for its immunosuppressive drug Tacrolimus. As a result, Atral Cipan will move the product through regulatory filings with the US Food and Drug Administration and European Medicines Agency for the manufacturing and marketing of Tacrolimus.

Swiss tool maker Starrag to set up Bangalore plant

Swiss-based machine tool maker Starrag Group will open its first manufacturing plant in Bangalore with an investment of R70 crore. This was one of the first investment proposals promised at the Global Investors Meet, 2010 organised by the Karnataka government. The factory in Devanahalli will employ around 300 people.

Ads by Google

Single Page Format

Previous | 1 | 2 | 3

Renault India commences first shipment of Duster to UK Zee president Jejurikar quits to return to M&MQuick view ZEE Oct-Dec quarter profit up 40 pc at Rs 193.31 cr

Previous Story We are on track to cross R4,000-crore mark this year Next Story ASUS VIVOBOOK F202E: Value for money

Reader's Comments| Post a Comment

Be the first to comment.